Published in Arthritis Rheum on October 15, 2006
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists. BMC Musculoskelet Disord (2009) 1.11
Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period. Ann Rheum Dis (2007) 0.95
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice. Mediators Inflamm (2014) 0.93
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy. Arthritis Res Ther (2010) 0.91
Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis. Arthritis Res Ther (2009) 0.91
Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study. Biologics (2013) 0.86
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort. Arthritis Res Ther (2016) 0.77
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis. Open Access Rheumatol (2009) 0.75
Retroperitoneal fibrosis. Lancet (2006) 4.57
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med (2007) 3.81
2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis (2012) 3.47
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum (2005) 3.31
Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet (2011) 3.19
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med (2004) 2.43
Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol (2007) 2.33
2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum (2012) 2.25
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia. J Rheumatol (2012) 2.18
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Rheumatology (Oxford) (2009) 1.76
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis (2013) 1.74
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum (2010) 1.67
Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) (2009) 1.60
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study. J Rheumatol (2011) 1.52
Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) (2009) 1.49
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? Arthritis Care Res (Hoboken) (2012) 1.46
Clinical characteristics of flexed posture in elderly women. J Am Geriatr Soc (2003) 1.43
The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum (2002) 1.43
Isolated aortitis versus giant cell arteritis: are they really two sides of the same coin? Clin Exp Rheumatol (2014) 1.43
EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis (2010) 1.38
An unusual cause of dysphagia. J Rheumatol (2012) 1.38
Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease. Nat Genet (2013) 1.34
Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum (2008) 1.30
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Ileal pouchitis-related arthritis. Semin Arthritis Rheum (2002) 1.23
Enthesitis. Best Pract Res Clin Rheumatol (2006) 1.21
Patient-reported outcomes in polymyalgia rheumatica. J Rheumatol (2012) 1.20
Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol (2006) 1.19
Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol (2009) 1.17
The effectiveness and safety of TNF-alpha blockers in the treatment of early psoriatic arthritis: an Italian multicentre longitudinal observational pilot study. Clin Rheumatol (2011) 1.15
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging (2011) 1.12
Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta (2012) 1.09
Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol (2007) 1.09
Pharmacological management of SAPHO syndrome. Expert Opin Investig Drugs (2006) 1.08
Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev (2012) 1.08
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum (2007) 1.07
Psoriatic arthritis: a systematic review. Int J Rheum Dis (2010) 1.07
Dactylolysis spontanea or ainhum involving the big toe. J Rheumatol (2005) 1.05
(18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum (2005) 1.05
Is (18)F fluorodeoxyglucose positron emission tomography useful to assess activity of myositis? J Rheumatol (2013) 1.05
The HLA-B*2709 subtype in a woman with early ankylosing spondylitis. Arthritis Rheum (2007) 1.04
Hepatitis C virus and arthritis. Rheum Dis Clin North Am (2003) 1.04
Diagnosis and treatment of giant cell arteritis. Drugs Aging (2008) 1.03
Diffuse idiopathic skeletal hyperostosis: differentiation from ankylosing spondylitis. Curr Rheumatol Rep (2009) 1.03
Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunol Res (2015) 1.03
International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. Arthritis Rheum (2009) 1.02
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel. Ann Rheum Dis (2010) 1.02
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol (2002) 1.02
Hepatitis C virus-related arthritis. Autoimmun Rev (2008) 1.02
Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus. Ann Rheum Dis (2010) 1.01
New approaches in the treatment of Adamantiades-Behçet's disease. Curr Opin Rheumatol (2006) 1.01
Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int (2007) 1.01
Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol (2012) 1.00
Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Clin Chim Acta (2013) 1.00
Inflamed temporal artery: histologic findings in 354 biopsies, with clinical correlations. Am J Surg Pathol (2014) 1.00
Etanercept in the longterm treatment of patients with ankylosing spondylitis. J Rheumatol (2009) 1.00
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. Clin Exp Rheumatol (2011) 0.99
Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum (2004) 0.98
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum (2007) 0.98
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum (2006) 0.97
The role of infectious agents in the pathogenesis of vasculitis. Best Pract Res Clin Rheumatol (2008) 0.97
Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. J Rheumatol (2009) 0.96
Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum (2003) 0.96
Chronic widespread pain in the spectrum of rheumatological diseases. Best Pract Res Clin Rheumatol (2011) 0.95
Multidisciplinary approach to fibromyalgia: what is the teaching? Best Pract Res Clin Rheumatol (2011) 0.95
Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol (2006) 0.94
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. Rheumatology (Oxford) (2013) 0.94
Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab. Clin Exp Rheumatol (2011) 0.94
Seronegative spondyloarthritides. Best Pract Res Clin Rheumatol (2002) 0.94
Tumor necrosis factor-alpha protects synovial cells from nitric oxide induced apoptosis through phosphoinositide 3-kinase Akt signal transduction. J Rheumatol (2006) 0.93
Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum (2002) 0.93
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann Rheum Dis (2012) 0.93
Vascular endothelial growth factor gene polymorphisms in giant cell arteritis. J Rheumatol (2003) 0.92
Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine (2010) 0.92